Concepedia

Jayakumar Warrier

JW

Statistics

Publications

10

Citations

311

H-Index

10

Active since

2004

Affiliations

Bristol-Myers Squibb (United States)(Current)

Biocon (India)

Université de Montréal

Bristol-Myers Squibb (India)

Syngene International (India)

Jayakumar Warrier is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and natural sciences.

Publications per year

2004–2020

10

Publications

10

Optimization of the Catalytic Asymmetric Addition of Nitroalkanes to Cyclic Enones with <i>trans</i>-4,5-Methano-<scp>l</scp>-proline

Stephen Hanessian, Zhihui Shao, Jayakumar Warrier · Organic Letters · 2006 · 72 citations

, , +12

Catalysis of the Hajos—Parrish—Eder—Sauer—Wiechert Reaction by <i>cis</i>‐ and <i>trans</i>‐4,5‐Methanoprolines: Sensitivity of Proline Catalysis to Pyrrolidine Ring Conformation

Paul Ha‐Yeon Cheong, K. N. Houk, Jayakumar Warrier et al. · Advanced Synthesis & Catalysis · 2004 · 62 citations

, , +12

Heterobicyclic inhibitors of transforming growth factor beta receptor I (TGFβRI)

Lalgudi S. Harikrishnan, Jayakumar Warrier, Andrew J. Tebben et al. · Bioorganic & Medicinal Chemistry · 2018 · 36 citations · Full text

, , +12

Probing the “additive effect” in the proline and proline hydroxamic acid catalyzed asymmetric addition of nitroalkanes to cyclic enones

Stephen Hanessian, Subramaniyan Govindan, Jayakumar Warrier · Chirality · 2005 · 31 citations

, , +11

Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent

Upender Velaparthi, Chetan Padmakar Darne, Jayakumar Warrier et al. · ACS Medicinal Chemistry Letters · 2020 · 28 citations · Full text

, , +15

1–5 of 10